TMO
Thermo Fisher ScientificNYSEHealth CareDiagnostics & ResearchSnapshot 2026-05-08
As of May 8, 2026, TMO has a composite score of 14.0 and a signal label of "mild favorable." The score is influenced by a medium confidence level of 76.1 and strengths in quality (78.3) and macro factors (31.5). The analysis is provisional and reflects various scenarios that could impact the score, including potential guidance changes and sector trends.
Price
Daily closes from AlphaVantage. Earnings/event dots are placed inline.
Factor signals
Read top-to-bottom: thesis (is this a strong company over a 1–3 year hold), watch flags (has something changed worth re-reading), and position context (how violent might the path be). Each pill is a parallel diagnostic — never aggregated into a single score.
Thesis
— is this a strong company over a 1–3 year hold?Why this rank
- Direction share1.00
- Slope (norm)0.04
- Bonus0.00
Why this rank
Trailing four: 2024-Q3, 2025-Q1, 2025-Q2, 2025-Q3
Why this rank
Watch
— has something changed worth re-reading?Why this setup
EPS estimate $5.81 → $5.72 (-1.5% / 30d). 2 raised, 12 cut, 14 covering analysts.
0 upgrades, 0 downgrades / 30d, 3 maintained. 92% of analysts rate Buy.
3 PT revisions / 30d. Avg target 32.2% above current price.
0 positive, 0 negative / 30d.
F4 · Management deep-dive — recent events, stated priorities, guidance track record
Recent 8-K events
7 material events in the last 24 months — top 5 listed below.
Stated priorities
2 priorityies extracted from earnings transcripts (as of 2026-05-08).
- 1.Complete acquisition of Clario Holdingsgrowthbehind14% progress
3/24: “Thermo Fisher announced the completion of its acquisition of Clario Holdings.”
Why this status
Newly stated in 2026-Q1. The acquisition of Clario Holdings was completed as announced, indicating progress in expanding service offerings. No specific financial impact was detailed in the provided data, but the acquisition aligns with growth strategy.
- 2.Announce share buyback programcapital allocationmixed44% progress
2/12: “Thermo Fisher announced a share buyback program with the issuance of senior notes.”
Why this status
Newly stated in 2026-Q1. Thermo Fisher announced a share buyback program, supported by the issuance of senior notes. The financials do not yet reflect the impact of this buyback, indicating it is in the early stages of execution.
Guidance track record
Insufficient guidance history for this ticker.
Position context
— how violent might the path be while I hold it?Why this risk level
Recent vol — 30d annualized 39%; 252d 31%.
Drawdown — Max 1y −28%. Bad day move −3%.
Beta to sector ETF (XLV) — 1.21 over 1y.
Liquidity — score 100/100.
Sub-scores — vol 48/100, drawdown 45/100, beta 79/100, earnings vol —.
via XLV
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive — historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only — describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-05-08.
What changed
The most important moves since the prior daily snapshot.
- No material changes since the prior snapshot.
No material changes since the prior snapshot.
as of 2026-05-08
Management scorecard
How management runs the business — capital, margins, balance sheet, and how reliably they guide and deliver.
What management is focused on
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
- #1
Complete acquisition of Clario Holdings
GrowthThermo Fisher aims to complete the acquisition of Clario Holdings to enhance its service offerings.
BehindNewly stated in 2026-Q1. The acquisition of Clario Holdings was completed as announced, indicating progress in expanding service offerings. No specific financial impact was detailed in the provided data, but the acquisition aligns with growth strategy.
14%CEO/CFO:“Thermo Fisher announced the completion of its acquisition of Clario Holdings.”Press releaseSource dated 2026-03-24Stated 1 of last 8 quartersFirst seen 2026-03-24Show history (1)
- 2026-Q1Press release
“Thermo Fisher announced the completion of its acquisition of Clario Holdings.”
- #2
Announce share buyback program
Capital allocationThermo Fisher announced a share buyback program to return value to shareholders.
MixedNewly stated in 2026-Q1. Thermo Fisher announced a share buyback program, supported by the issuance of senior notes. The financials do not yet reflect the impact of this buyback, indicating it is in the early stages of execution.
44%CEO/CFO:“Thermo Fisher announced a share buyback program with the issuance of senior notes.”Press releaseSource dated 2026-02-12Stated 1 of last 8 quartersFirst seen 2026-02-12Show history (1)
- 2026-Q1Press release
“Thermo Fisher announced a share buyback program with the issuance of senior notes.”
How this stock is priced
Two ways to read price: against peers in the same business, and against the company's own history.
Looks more expensive than peers.
Self-history needs ~20 months of data.
P/E over the last 5 years
0 monthly pointsHow this compares
A side-by-side read on composite, valuation, and risk versus peers.
| Stock | Composite | Valuation | Risk |
|---|---|---|---|
TMO Thermo Fisher Scientific | +14 | full | moderate |
LLY Lilly (Eli) | +21 | full | moderate |
JNJ Johnson & Johnson | +18 | full | low |
ABBV AbbVie | +12 | fair | low |
UNH UnitedHealth Group | +24 | fair | elevated |
Risk — how this stock moves
What a normal day looks like, what a bad day looks like, and the worst the last year has thrown at it.
What could change this view
Conditional scenarios — if X happens, the score would shift by about Y points. These are not predictions.
- If health_care sector trend rises from +0.06 into 'improving' (>= +0.20)+5.0 pts
- If next-quarter guidance is raised (currently NEW as of 2026-04-23)+4.0 pts
- If next-quarter guidance is cut (currently NEW as of 2026-04-23)-8.0 pts
- If labor state reverses from -0.31 (negative) to +0.31 (positive)-6.8 pts
- If health_care sector trend falls from +0.06 into 'weakening' (<= -0.20)-5.0 pts
Material updates
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
- 2026-04-2315d agoItem 2.02
Results of Operations and Financial Condition. On April 23, 2026, the Registrant announced its financial results for the fiscal quarter ended March 28, 2026. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Form 8-K and incorporated herein by reference. The information contained in this report and exhibits hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") o…
earnings preannouncementneutralscore 46 - 2026-03-241mo agoItem 8.01
Other Events. On March 24, 2026, Thermo Fisher Scientific Inc. (“Thermo Fisher”) issued a press release announcing the completion of its acquisition of Clario Holdings, Inc. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
mna activitypositivescore 18 - 2026-02-122mo agoItem 1.01
Entry into a Material Definitive Agreement. On February 12, 2026, Thermo Fisher Scientific Inc. (the “Company”) issued $1,000,000,000 aggregate principal amount of 4.215% Senior Notes due 2031 (the “2031 Notes”), $750,000,000 aggregate principal amount of 4.550% Senior Notes due 2033 (the “2033 Notes”), $1,300,000,000 aggregate principal amount of 4.902% Senior Notes due 2036 (the “2036 Notes”) and $750,000,000 aggregate principal amount of 5.546% Senior Notes due 2046 (the “2046 Notes” and,…
capital allocationpositivescore 9 - 2026-02-122mo agoItem 8.01
Other Events. The sale of the Notes was made pursuant to the terms of an Underwriting Agreement, which the Company entered into on February 9, 2026 (the “Underwriting Agreement”), with Deutsche Bank Securities Inc., RBC Capital Markets, LLC, SMBC Nikko Securities America, Inc. and Wells Fargo Securities, LLC, as representatives of the several underwriters named in Schedule A to the Underwriting Agreement. The Company expects that the net proceeds from the sale of the Notes will be approximate…
capital allocationpositivescore 7 - 2026-01-293mo agoItem 2.02
Results of Operations and Financial Condition. On January 29, 2026, the Registrant announced its financial results for the fiscal quarter and year ended December 31, 2025. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Form 8-K and incorporated herein by reference. The information contained in this report and exhibits hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Ex…
earnings preannouncementneutralscore 7
Score history
The composite score, snapshot by snapshot. The dotted line at zero separates leaning-positive from leaning-negative.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.